Expediting Patient Access to New Health Technologies: Role of Disease-Specific Reference Models

Multivariable and Structural Uncertainty Analyses for Cost-Effectiveness Estimates: Back to the Future

(2019) Josephine Mauskopf   VALUE IN HEALTH

Transparency in Decision Modelling: What, Why, Who and How?

(2019) Christopher James Sampson et al.   PHARMACOECONOMICS

Structuring a conceptual model for cost-effectiveness analysis of frailty interventions

(2019) Hossein Haji Ali Afzali et al.   PLoS One

Improving Decision-Making Processes in Health: Is It Time for (Disease-Specific) Reference Models?

(2019) Hossein Haji Ali Afzali et al.   Applied Health Economics and Health Policy

Model Structuring for Economic Evaluations of New Health Technologies

(2018) Hossein Haji Ali Afzali et al.   PHARMACOECONOMICS

The Importance of Model Structure in the Cost-Effectiveness Analysis of Primary Care Interventions for the Management of Hypertension

(2018) Maria Cristina Peñaloza-Ramos et al.   VALUE IN HEALTH

Critical Analysis of Markov Models Used for the Economic Evaluation of Colorectal Cancer Screening: A Systematic Review

(2018) Nicolas Silva-Illanes et al.   VALUE IN HEALTH

Identifying the Need for Good Practices in Health Technology Assessment: Summary of the ISPOR HTA Council Working Group Report on Good Practices in HTA

(2018) Finn Børlum Kristensen et al.   VALUE IN HEALTH

Estimating the Reference Incremental Cost-Effectiveness Ratio for the Australian Health System

(2017) Laura Catherine Edney et al.   PHARMACOECONOMICS

Development and Use of Disease-Specific (Reference) Models for Economic Evaluations of Health Technologies: An Overview of Key Issues and Potential Solutions

(2015) Gerardus W. J. Frederix et al.   PHARMACOECONOMICS

Exploring Structural Uncertainty in Model-Based Economic Evaluations

(2015) Hossein Haji Ali Afzali et al.   PHARMACOECONOMICS

Accelerated Access to Innovative Medicines for Patients in Need

(2014) L G Baird et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Decision-Analytic Models: Current Methodological Challenges

(2014) J. Jaime Caro et al.   PHARMACOECONOMICS

The Impact of Structural Uncertainty on Cost-Effectiveness Models for Adjuvant Endocrine Breast Cancer Treatments: the Need for Disease-Specific Model Standardization and Improved Guidance

(2013) Gerardus W. J. Frederix et al.   PHARMACOECONOMICS

The Cloudy Crystal Ball of Cost-Effectiveness Studies

(2013) Gerardus W.J. Frederix et al.   VALUE IN HEALTH

Improving the Accuracy and Comparability of Model-Based Economic Evaluations of Health Technologies for Reimbursement Decisions

(2012) Hossein Haji Ali Afzali et al.   MEDICAL DECISION MAKING

Modeling Good Research Practices—Overview

(2012) J. Jaime Caro et al.   MEDICAL DECISION MAKING

A Critical Review of Model-Based Economic Studies of Depression

(2012) Hossein Haji Ali Afzali et al.   PHARMACOECONOMICS

Whole Disease Modeling to Inform Resource Allocation Decisions in Cancer: A Methodological Framework

(2012) Paul Tappenden et al.   VALUE IN HEALTH

Addressing the Challenge for Well Informed and Consistent Reimbursement Decisions

(2011) Hossein Haji Ali Afzali et al.   PHARMACOECONOMICS